A significant breakthrough in cancer study is emerging with the use of mini-antibodies to restore damaged p53. This essential malignant protector protein is frequently inactivated in various forms of cancer, leading https://ztndz.com/story29823244/mini-antibodies-revive-the-p53-protein-a-new-pathway-for-malignant-management